glp-1 and pancreatitis Receptor Agonists as Treatments for Type 2 Diabetes Updates in Medicine | GLP-1s

Gavin Thompson, co-founder and co-CEO of Phoenix, states, There is a misconception that weight loss is only an issue of vanity

Sample sections were blocked in 5 % goat serum with 0.3 % Triton X-100 for 1 h at RT and then incubated overnight at 4 C with the following primary antibodies: mouse anti-GLP-1R (1:50, Santa Cruz, CA, USA), mouse anti-GLP-1(1:50, Santa Cruz, CA, USA), rabbit anti-Iba1 (1:500, Wako Chemicals, Tokyo, Japan), rabbit anti-GFAP (1:200, Cell Signalling, Boston, MA, USA), rabbit anti-NeuN (1:100, Proteintech, China), mouse anti-CGRP (1:100, Santa Cruz, CA, USA), and mouse anti-c-fos (1:100, Santa Cruz, CA, USA)

Additionally, nearly 60% of European adults are overweight or obese, increasing the risk of type 2 diabetes and metabolic complications

Diabetes 61: 1250-1262, 2012

Although these studies cannot prove causation, the consistent findings across large populations, systems, and countries provide compelling early evidence that GLP-1 medications could reduce alcohol and drug use and could play an important role in SUD treatment

Mild nausea in the first day or two is common